These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1414 related items for PubMed ID: 31254236

  • 1. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A, Lorenzin M, Tadiotto G, Russo FP, Oliviero F, Felicetti M, D'Incà R, Favero M, Piaserico S, Doria A, Ramonda R.
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [Abstract] [Full Text] [Related]

  • 2. Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis.
    Babakinejad P, Lapsley R, Forster L, McPherson S, Pearce MS, Reynolds NJ, Slack E, Weatherhead SC, Hampton PJ.
    Br J Dermatol; 2024 Jul 16; 191(2):275-283. PubMed ID: 38366967
    [Abstract] [Full Text] [Related]

  • 3. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC, Hung HF, Lu CW, Chang HH, Lee LT, Huang KC.
    Sci Rep; 2016 Jun 01; 6():27034. PubMed ID: 27246655
    [Abstract] [Full Text] [Related]

  • 4. A cross-sectional study on the prevalence of metabolic syndrome in psoriasis compared to psoriatic arthritis.
    Bostoen J, Van Praet L, Brochez L, Mielants H, Lambert J.
    J Eur Acad Dermatol Venereol; 2014 Apr 01; 28(4):507-11. PubMed ID: 24772493
    [Abstract] [Full Text] [Related]

  • 5. Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.
    Loganathan A, Kamalaraj N, El-Haddad C, Pile K.
    Int J Rheum Dis; 2021 Sep 01; 24(9):1112-1120. PubMed ID: 34076348
    [Abstract] [Full Text] [Related]

  • 6. Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing.
    Su YJ.
    Clin Rheumatol; 2020 Dec 01; 39(12):3677-3684. PubMed ID: 32468320
    [Abstract] [Full Text] [Related]

  • 7. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
    Gelfand JM, Wan J, Zhang H, Shin DB, Ogdie A, Syed MN, Egeberg A.
    J Am Acad Dermatol; 2021 Jun 01; 84(6):1636-1643. PubMed ID: 33607181
    [Abstract] [Full Text] [Related]

  • 8. Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
    Chavez-Tapia NC, Sanchez-Jimenez BA, Vidaña-Perez D, Corrales-Rosas B, Balderas-Garces B, Vera-Izaguirre D, Santa Cruz FJ, Maldonado-Garcia C, Juarez-Hernandez E, Uribe M.
    PLoS One; 2024 Jun 01; 19(4):e0290632. PubMed ID: 38626012
    [Abstract] [Full Text] [Related]

  • 9. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
    Andreozzi P, Viscogliosi G, Colella F, Subic M, Cipriani E, Marigliano B, Verrusio W, Servello A, Ettorre E, Marigliano V.
    Recenti Prog Med; 2012 Dec 01; 103(12):570-4. PubMed ID: 23258240
    [Abstract] [Full Text] [Related]

  • 10. Liver Stiffness Measurement in Psoriasis: Do Metabolic or Disease Factors Play the Important Role?
    Pongpit J, Porntharukchareon S, Kaewduang P, Promson K, Stitchantrakul W, Petraksa S, Thakkinstian A, Kositchaiwat C, Rajatanavin N, Sobhonslidsuk A.
    Biomed Res Int; 2016 Dec 01; 2016():7963972. PubMed ID: 27006950
    [Abstract] [Full Text] [Related]

  • 11. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R, Ruiz A, Torres-Robles R, Chávez-Tapia N, Méndez-Sánchez N, Arrese M.
    J Eur Acad Dermatol Venereol; 2015 Apr 01; 29(4):656-62. PubMed ID: 25418531
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
    Bellinato F, Gisondi P, Mantovani A, Girolomoni G, Targher G.
    J Endocrinol Invest; 2022 Jul 01; 45(7):1277-1288. PubMed ID: 35147926
    [Abstract] [Full Text] [Related]

  • 15. Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity.
    Eder L, Jayakar J, Pollock R, Pellett F, Thavaneswaran A, Chandran V, Rosen CF, Gladman DD.
    Ann Rheum Dis; 2013 Dec 01; 72(12):1956-61. PubMed ID: 23243196
    [Abstract] [Full Text] [Related]

  • 16. The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.
    Campanati A, Ganzetti G, Di Sario A, Damiani A, Sandroni L, Rosa L, Benedetti A, Offidani A.
    J Gastroenterol; 2013 Jul 01; 48(7):839-46. PubMed ID: 23065020
    [Abstract] [Full Text] [Related]

  • 17. Association of Behçet disease with psoriasis and psoriatic arthritis.
    Hahn HJ, Kwak SG, Kim DK, Kim JY.
    Sci Rep; 2021 Jan 28; 11(1):2531. PubMed ID: 33510251
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography.
    Lai LL, Wan Yusoff WNI, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK.
    J Gastroenterol Hepatol; 2019 Aug 28; 34(8):1396-1403. PubMed ID: 30551263
    [Abstract] [Full Text] [Related]

  • 20. Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).
    van der Voort EAM, Wakkee M, Veldt-Kok P, Darwish Murad S, Nijsten T.
    Br J Dermatol; 2017 Jun 28; 176(6):1599-1606. PubMed ID: 27925155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.